作者：
Gianluca,Giannarini [1]
;
Neeraj,Agarwal [2]
;
Andrea B,Apolo [3]
;
Alberto,Briganti [4]
;
Petros,Grivas [5]
;
Shilpa,Gupta [6]
;
Ashish M,Kamat [7]
;
Francesco,Montorsi [4]
;
Morgan,Rouprêt [8]
;
Andrea,Necchi [9]
作者单位：
Urology Unit, Santa Maria della Misericordia University Hospital, Udine, Italy. Electronic address: gianluca.giannarini@hotmail.it.
[1]
Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
[2]
Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
[3]
Urology Unit, IRCCS San Raffaele Scientific Institute, Vita Salute University, Milan, Italy; Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.
[4]
Department of Medicine, Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, WA, USA.
[5]
Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
[6]
Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[7]
GRC 5 Predictive Onco-Uro, Sorbonne University, Urology, Pitié-Salpêtrière Hospital AP-HP, Paris, France.
[8]
Urology Unit, IRCCS San Raffaele Scientific Institute, Vita Salute University, Milan, Italy; Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Vita Salute University, Milan, Italy.
[9]
DOI
10.1016/j.euo.2021.05.008
PMID
34147473
发布时间
2022-09-14
换一批
换一批
